BCRX

NASD BioCryst Pharmaceuticals, Inc.

Oct 27, 2026 · 11:38 PM ET EOD Market Closed

$8.10 ↑ +0.00 (+0.00%) Trading Up from the previous close of $8.10, $0.02 below the day’s high of $8.12

YTD change: +3.85%
vs 20-day SMA: +0.28%
vs 200-day SMA: -7.11%

Price ranges

Previous day

$7.66 $8.00

open $7.69 close $7.88

+$0.19 (+2.47%)

Today

$7.81 $8.12

open $7.88 now $8.10

+$0.22 (+2.79%)

Past week

$7.52 $8.13

from $8.07 now $8.10

+$0.03 (+0.37%)

Past month

$7.52 $8.60

from $8.47 now $8.10

-$0.37 (-4.37%)

This year

$6.23 $11.22

from $7.80 now $8.10

+$0.30 (+3.85%)

Price & Performance

-0.80 (-8.99%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 59.5% away from all-time highs of $19.99
BCRX is up 4% since the beginning of the year
BCRX is up 11% over the past 12 months
BCRX is down 4% over the past 1 month
13% of all BCRX investors are betting against BCRX

BCRX reads neutral: price sits above one of the two key moving averages, the 12-month move is +10.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.3

Earnings momentum -226.6% Quarterly EPS growth

Quarterly change -226.6%

Valuation

P/E ratio N/A

Enterprise value $2.6B

Beta 0.59

Balance sheet & scale

IncomeN/A

Revenue$940.6M

Cash$353.1M

Debt$836.6K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $2.1B

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Competitor comparison

Ticker	Company	Price	Change
CSLLY	CSL Limited Sponsored ADR	$34.64	+1.41%
ARGX	argenx SE Sponsored ADR	$882.48	+1.51%
ONC	BeOne Medicines Ltd. Sponsored ADR	$366.06	-1.30%
INCY	Incyte Corporation	$116.60	+2.90%
WXXWY	WuXi Biologics (Cayman) Inc. Unsponsored ADR	$11.53	-1.45%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.